LIVE QUOTE
Mettler-Toledo International Inc. MTD
Healthcare · Medical - Diagnostics & Research · NYSE
$1,162.79
Market Cap$28.0B
P/E Ratio32.0
Beta1.26
Employees16,000

Investment Thesis

. A price decline below $1,100 or unexpected negative earnings guidance would warrant a reassessment of the position.

Competitive Moat

MTD possesses a strong competitive moat characterized by intangible assets, particularly its brand reputation for quality and innovation, along with significant switching costs for customers reliant on its precision instruments. The durability of this advantage over the next 5-10 years is reinforced by proprietary technologies and a comprehensive service and support network that customers value. However, competitive threats from lower-cost providers or advancements in alternative technologies pose risks that could erode MTD's market share.

Growth Engine

Future revenue growth for MTD will stem primarily from the expanding total addressable market (TAM) in the healthcare and industrial sectors, projected to grow significantly due to increased investment in R&D and automation. MTD is expected to leverage its pricing power effectively, particularly as the demand for high-quality analytical tools rises. The company is gaining market share organically, supported by a robust pipeline of new products and enhancements to its existing offerings, particularly in its LabX software platform.

This analysis is AI-generated using publicly available market data and is for informational purposes only. It does not constitute investment advice. Always conduct your own research before making investment decisions.
Morningstar Investor
Analyst ratings, fair value, moat
Research MTD
Robinhood
$0 commission trades
Trade MTD
Webull
Extended-hours, options, charts
Trade MTD
TradingView
Advanced charts & screeners
Chart MTD
We may earn a commission if you open an account through our links, at no extra cost to you.
Loading chart...

Frequently Asked Questions

As of 2026-06-11, MTD has a P/E ratio that is not available, which may indicate that the stock is either not profitable or that earnings are not reported. Without a market cap provided, it is difficult to assess its valuation relative to others in the healthcare sector.
MTD does not currently pay a dividend, as there is no dividend yield information available.
MTD operates in the healthcare sector, specifically within the medical diagnostics and research industry.
The market cap for MTD is not available, which makes it challenging to categorize the company within the typical market cap classifications.
MTD's competitors in the medical diagnostics and research industry include companies such as Thermo Fisher Scientific and Agilent Technologies.
FAQ generated 2026-06-11

Related Reading

Related Stocks

← View in Stock Screener
Disclaimer: Stock data sourced from Financial Modeling Prep, updated daily. Prices may be delayed. Interactive charts powered by TradingView. This page is for informational and educational purposes only and does not constitute investment advice. We are not licensed financial advisors. Past performance is not indicative of future results. All investments carry risk, including the possible loss of principal. Please consult a qualified professional before making investment decisions.

Privacy Policy · Terms